|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/13 | (2006.01) |
| A61K 31/445 | (2006.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 3458039 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16763575.4 |
| Date of filing the European patent application | 2016-08-03 | |
| (97) | Date of publication of the European application | 2019-03-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
| (46) | Date of publication of the claims translation | 2020-11-25 |
| (86) | Number | PCT/IB2016/054672 |
| Date | 2016-08-03 |
| (87) | Number | WO 2017/199070 |
| Date | 2017-11-23 |
| (30) | Number | Date | Country code |
| 201641017204 | 2016-05-18 | IN |
| (72) |
NIROGI, Ramakrishna, IN
SHINDE, Anil Karbhari, IN
JAYARAJAN, Pradeep, IN
BHYRAPUNENI, Gopinadh, IN
KAMBHAMPATI, Ramasastri, IN
JASTI, Venkateswarlu, IN
|
| (73) |
Suven Life Sciences Limited,
Serene Chambers Road - 5 Avenue - 7 Banjara Hills, Hyderabad, Telangana 500034,
IN
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Trijų komponentų derinys, susidedantis iš grynų 5-HT6 receptoriaus antagonistų, acetilcholinesterazės inhibitorių ir NMDA receptoriaus antagonisto |
| TRIPLE COMBINATION OF PURE 5-HT6 RECEPTOR ANTAGONISTS, ACETYLCHOLINESTERASE INHIBITORS AND NMDA RECEPTOR ANTAGONIST |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 10 | 231.00 EUR |
| 2026-08-03 |